McKinsey to Pay $650 Million in Opioid Settlement, But Executives Avoid Charges
2024-12-14
Global consulting giant McKinsey & Company agreed to pay $650 million to settle a federal probe into its role in boosting opioid sales. While McKinsey admitted its strategies led to unsafe and unnecessary opioid prescriptions, and a former senior partner pleaded guilty to destroying documents, other executives escaped criminal charges. This highlights the ongoing issue of large corporations paying hefty fines for their role in the opioid crisis while their top executives rarely face consequences, raising concerns about corporate accountability.